{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:18:22Z","timestamp":1777871902723,"version":"3.51.4"},"reference-count":149,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute On Drug Abuse of the National Institutes of Health","award":["R01DA061367"],"award-info":[{"award-number":["R01DA061367"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    Despite robust evidence that medications for opioid use disorder (MOUD) reduce overdose and mortality, substantial care gaps remain following opioid-related hospital encounters. The opioid use disorder (OUD) Cascade of Care framework conceptualizes progression from identification to treatment initiation and retention, yet limited research has examined how real-world OUD treatment trajectories unfold, particularly across treatment episodes and multiple care settings. This paper describes an NIH-funded study protocol\n                    <jats:italic>(1R01DA061367-01A1)<\/jats:italic>\n                    to conduct a longitudinal observational study using linked administrative data across New York City to characterize OUD treatment trajectories following opioid-related hospital encounters. Using the OUD Cascade of Care framework, we will apply state sequence analysis to identify common patterns of OUD treatment engagement in the year following hospitalization, including transitions between treatment modalities and periods in and out of care. We will examine how care trajectories vary by individual and neighborhood characteristics, and assess associations between trajectories and key outcomes, including rehospitalization, overdose, and mortality. By applying novel data-driven longitudinal methods, this study will advance understanding of the complex, non-linear nature of OUD treatment engagement. Findings will inform health system and policy efforts to identify populations at elevated risk, hospital-based interventions, and opportunities to address gaps in care to reduce overdose-related harms.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0345769","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T17:32:41Z","timestamp":1777570361000},"page":"e0345769","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characterizing complex opioid use disorder care trajectories and outcomes following acute service utilization: A protocol for a population-based data linkage study"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7396-3938","authenticated-orcid":true,"given":"Noa","family":"Krawczyk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3746-578X","authenticated-orcid":true,"given":"Ignacio","family":"B\u00f3rquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Woo","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7766-6076","authenticated-orcid":true,"given":"Teena","family":"Cherian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Schatz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Harocopos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Carter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0667-9283","authenticated-orcid":true,"given":"Brandy F.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Frank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Cerd\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur Robin","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"pone.0345769.ref001","article-title":"Fatal Injury Trends","volume-title":"Web-based Injury Statistics Query and Reporting System","author":"CDC","year":"2025"},{"key":"pone.0345769.ref002","author":"National Vital Statistics System","year":"2025"},{"key":"pone.0345769.ref003","year":"2025"},{"key":"pone.0345769.ref004"},{"key":"pone.0345769.ref005","doi-asserted-by":"crossref","DOI":"10.17226\/25310","volume-title":"Medications for opioid use disorder save lives","author":"AI Leshner","year":"2019"},{"key":"pone.0345769.ref006","doi-asserted-by":"crossref","first-page":"103786","DOI":"10.1016\/j.drugpo.2022.103786","article-title":"Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019\"","volume":"110","author":"N Krawczyk","year":"2022","journal-title":"Int J Drug Policy"},{"issue":"9","key":"pone.0345769.ref007","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/jama.2024.11977","article-title":"Major Gaps in the Cascade of Care for Opioid Use Disorder: Implications for Clinical Practice","volume":"332","author":"MA Arwady","year":"2024","journal-title":"JAMA"},{"key":"pone.0345769.ref008","author":"Substance Abuse and Mental Health Services Administration","year":"2025"},{"key":"pone.0345769.ref009","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jsat.2019.07.010","article-title":"Prescribing decisions at buprenorphine treatment initiation: Do they matter for treatment discontinuation and adverse opioid-related events?","volume":"105","author":"A Meinhofer","year":"2019","journal-title":"J Subst Abuse Treat"},{"key":"pone.0345769.ref010","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jsat.2017.07.001","article-title":"Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population","volume":"85","author":"JR Morgan","year":"2018","journal-title":"J Subst Abuse Treat"},{"issue":"7","key":"pone.0345769.ref011","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/MLR.0000000000000727","article-title":"Patterns of Buprenorphine-Naloxone Treatment for Opioid Use Disorder in a Multistate Population","volume":"55","author":"B Saloner","year":"2017","journal-title":"Med Care"},{"issue":"7","key":"pone.0345769.ref012","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/add.14180","article-title":"Extended-release injectable naltrexone for opioid use disorder: a systematic review","volume":"113","author":"BP Jarvis","year":"2018","journal-title":"Addiction"},{"key":"pone.0345769.ref013","doi-asserted-by":"crossref","first-page":"108329","DOI":"10.1016\/j.jsat.2021.108329","article-title":"Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings","volume":"126","author":"N Krawczyk","year":"2021","journal-title":"J Subst Abuse Treat"},{"key":"pone.0345769.ref014","article-title":"From opioid maintenance to abstinence: a literature review","author":"K Hege","year":"2004","journal-title":"Unit Addict Med Univ Oslo"},{"key":"pone.0345769.ref015","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.drugalcdep.2007.11.003","article-title":"Mortality prior to, during and after opioid maintenance treatment (OMT): a national prospective cross-registry study","volume":"94","author":"T Clausen","year":"2008","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"pone.0345769.ref016","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1377\/hlthaff.2019.01085","article-title":"Impact Of Long-Term Buprenorphine Treatment On Adverse Health Care Outcomes In Medicaid","volume":"39","author":"H Samples","year":"2020","journal-title":"Health Aff (Millwood)"},{"issue":"1","key":"pone.0345769.ref017","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13722-017-0072-2","article-title":"Public sector low threshold office-based buprenorphine treatment: outcomes at year 7","volume":"12","author":"EP Bhatraju","year":"2017","journal-title":"Addict Sci Clin Pract"},{"issue":"2","key":"pone.0345769.ref018","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/10550490701860971","article-title":"Long-term treatment with buprenorphine\/naloxone in primary care: results at 2-5 years","volume":"17","author":"DA Fiellin","year":"2008","journal-title":"Am J Addict"},{"issue":"7396","key":"pone.0345769.ref019","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1136\/bmj.326.7396.959","article-title":"Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study","volume":"326","author":"J Strang","year":"2003","journal-title":"BMJ"},{"key":"pone.0345769.ref020","doi-asserted-by":"crossref","first-page":"107997","DOI":"10.1016\/j.drugalcdep.2020.107997","article-title":"Opioid overdose death following criminal justice involvement: Linking statewide corrections and hospital databases to detect individuals at highest risk","volume":"213","author":"N Krawczyk","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"pone.0345769.ref021","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1001\/jamapsychiatry.2021.0967","article-title":"Racial\/Ethnic, Social, and Geographic Trends in Overdose-Associated Cardiac Arrests Observed by US Emergency Medical Services During the COVID-19 Pandemic","volume":"78","author":"J Friedman","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"pone.0345769.ref022","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/add.15233","article-title":"African Americans now outpace whites in opioid-involved overdose deaths: a comparison of temporal trends from 1999 to 2018","volume":"116","author":"D Furr-Holden","year":"2021","journal-title":"Addiction"},{"key":"pone.0345769.ref023","year":"2024","journal-title":"Products - Data Briefs - Number 491 - March 2024"},{"key":"pone.0345769.ref024","year":"2022","journal-title":"Drug overdose deaths in the United States, 2001-2021"},{"issue":"4","key":"pone.0345769.ref025","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/08897077.2018.1449166","article-title":"A population-based examination of trends and disparities in medication treatment for opioid use disorders among Medicaid enrollees","volume":"39","author":"BD Stein","year":"2018","journal-title":"Subst Abus"},{"issue":"5","key":"pone.0345769.ref026","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.5852","article-title":"Incidence of Treatment for Opioid Use Disorder Following Nonfatal Overdose in Commercially Insured Patients","volume":"3","author":"AS Kilaru","year":"2020","journal-title":"JAMA Netw Open"},{"key":"pone.0345769.ref027","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.drugalcdep.2015.12.035","article-title":"Characteristics of veterans receiving buprenorphine vs. methadone for opioid use disorder nationally in the Veterans Health Administration","volume":"160","author":"A Manhapra","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"pone.0345769.ref028","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/00380237.2009.10571347","article-title":"Racial and Ethnic Composition as a Correlate of Medication Availability within Addiction Treatment Organizations","volume":"42","author":"HK Knudsen","year":"2009","journal-title":"Sociol Focus"},{"issue":"5","key":"pone.0345769.ref029","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.amepre.2022.05.006","article-title":"Racial\u2012Ethnic Disparities of Buprenorphine and Vivitrol Receipt in Medicaid","volume":"63","author":"CC Dunphy","year":"2022","journal-title":"Am J Prev Med"},{"issue":"19","key":"pone.0345769.ref030","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMsa2212412","article-title":"Racial Inequality in Receipt of Medications for Opioid Use Disorder","volume":"388","author":"ML Barnett","year":"2023","journal-title":"N Engl J Med"},{"issue":"2","key":"pone.0345769.ref031","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1080\/00952990.2023.2180382","article-title":"Telehealth for opioid use disorder: retention as a function of demographics and rurality","volume":"49","author":"AR Williams","year":"2023","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"1","key":"pone.0345769.ref032","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1001\/jamapsychiatry.2022.3673","article-title":"Racial and Ethnic Disparities in Buprenorphine Treatment Duration in the US","volume":"80","author":"H Dong","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"pone.0345769.ref033","doi-asserted-by":"crossref","first-page":"107113","DOI":"10.1016\/j.addbeh.2021.107113","article-title":"Systematic review and meta-analysis of retention in treatment using medications for opioid use disorder by medication, race\/ethnicity, and gender in the United States","volume":"124","author":"M Hochheimer","year":"2022","journal-title":"Addict Behav"},{"key":"pone.0345769.ref034","volume-title":"The politics of stigma and racialization in the early years of methadone maintenance regulation","author":"S Roberts","year":"2022"},{"key":"pone.0345769.ref035","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1377\/hlthaff.2020.02261","article-title":"Addressing racial and ethnic disparities in the use of medications for opioid use disorder","volume":"40","author":"B Andraka-Christou","year":"2021","journal-title":"Health Aff Proj Hope"},{"key":"pone.0345769.ref036","doi-asserted-by":"crossref","first-page":"108214","DOI":"10.1016\/j.jsat.2020.108214","article-title":"Addressing racial & socioeconomic disparities in access to medications for opioid use disorder amid COVID-19","volume":"122","author":"MJ Nguemeni Tiako","year":"2021","journal-title":"J Subst Abuse Treat"},{"key":"pone.0345769.ref037","doi-asserted-by":"crossref","first-page":"103931","DOI":"10.1016\/j.drugpo.2022.103931","article-title":"Multidimensional assessment of access to medications for opioid use disorder across urban and rural communities: A scoping review","volume":"112","author":"T Bommersbach","year":"2023","journal-title":"Int J Drug Policy"},{"issue":"3","key":"pone.0345769.ref038","doi-asserted-by":"crossref","DOI":"10.1111\/jrh.70076","article-title":"Rural and urban differences in treatment on demand for substance use treatment involving medications for opioid use disorder","volume":"41","author":"RJ Lofaro","year":"2025","journal-title":"J Rural Health"},{"key":"pone.0345769.ref039","year":"2023"},{"issue":"2","key":"pone.0345769.ref040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229174","article-title":"National U.S. time-trends in opioid use disorder hospitalizations and associated healthcare utilization and mortality","volume":"15","author":"JA Singh","year":"2020","journal-title":"PLoS One"},{"key":"pone.0345769.ref041","volume-title":"Opioid-Related Inpatient Stays and Emergency Department Visits by State 2009-2014","author":"A Weiss","year":"2016"},{"key":"pone.0345769.ref042","doi-asserted-by":"crossref","first-page":"108568","DOI":"10.1016\/j.drugalcdep.2021.108568","article-title":"Prevalence and charges of opioid-related visits to U.S. emergency departments","volume":"221","author":"JR Langabeer","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"pone.0345769.ref043","doi-asserted-by":"crossref","first-page":"107537","DOI":"10.1016\/j.drugalcdep.2019.06.039","article-title":"Touchpoints - Opportunities to predict and prevent opioid overdose: A cohort study","volume":"204","author":"MR Larochelle","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"16","key":"pone.0345769.ref044","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1001\/jama.2015.3474","article-title":"Emergency department-initiated buprenorphine\/naloxone treatment for opioid dependence: a randomized clinical trial","volume":"313","author":"G D\u2019Onofrio","year":"2015","journal-title":"JAMA"},{"key":"pone.0345769.ref045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2017.05.007","article-title":"Addiction consultation services - Linking hospitalized patients to outpatient addiction treatment","volume":"79","author":"P Trowbridge","year":"2017","journal-title":"J Subst Abuse Treat"},{"issue":"8","key":"pone.0345769.ref046","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1001\/jamainternmed.2014.2556","article-title":"Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial","volume":"174","author":"JM Liebschutz","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"1","key":"pone.0345769.ref047","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/ajad.12161","article-title":"Initiating buprenorphine treatment for hospitalized patients with opioid dependence: A case series","volume":"24","author":"J Suzuki","year":"2015","journal-title":"Am J Addict"},{"key":"pone.0345769.ref048","doi-asserted-by":"crossref","DOI":"10.1007\/s40429-019-00267-x","article-title":"Treatment of opioid use disorder in the acute hospital setting: a critical review of the literature (2014\u20132019)","volume":"6","author":"M Weimer","year":"2019","journal-title":"Curr Addict Rep"},{"issue":"5","key":"pone.0345769.ref049","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s11739-021-02636-9","article-title":"Guidelines for the assessment and management of addiction in the hospitalized patient with opioid use disorder: a twenty-first century update","volume":"16","author":"R Shmuts","year":"2021","journal-title":"Intern Emerg Med"},{"issue":"2","key":"pone.0345769.ref050","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/ADM.0000000000000496","article-title":"Role of the Hospital in the 21st Century Opioid Overdose Epidemic: The Addiction Medicine Consult Service","volume":"13","author":"KC Priest","year":"2019","journal-title":"J Addict Med"},{"issue":"12","key":"pone.0345769.ref051","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1007\/s11606-019-05251-9","article-title":"Inpatient Addiction Medicine Consultation and Post-Hospital Substance Use Disorder Treatment Engagement: a Propensity-Matched Analysis","volume":"34","author":"H Englander","year":"2019","journal-title":"J Gen Intern Med"},{"key":"pone.0345769.ref052","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jsat.2016.07.004","article-title":"Post-Discharge Treatment Engagement Among Patients with an Opioid-Use Disorder","volume":"69","author":"S Naeger","year":"2016","journal-title":"J Subst Abuse Treat"},{"issue":"8","key":"pone.0345769.ref053","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1007\/s11606-020-05815-0","article-title":"Opioid Agonist Therapy During Hospitalization Within the Veterans Health Administration: a Pragmatic Retrospective Cohort Analysis","volume":"35","author":"KC Priest","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"1","key":"pone.0345769.ref054","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00952990.2018.1546862","article-title":"Development of a Cascade of Care for responding to the opioid epidemic","volume":"45","author":"AR Williams","year":"2019","journal-title":"Am J Drug Alcohol Abuse"},{"key":"pone.0345769.ref055","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jsat.2018.06.001","article-title":"Developing an opioid use disorder treatment cascade: A review of quality measures","volume":"91","author":"AR Williams","year":"2018","journal-title":"J Subst Abuse Treat"},{"key":"pone.0345769.ref056","author":"A Williams","year":"2017","journal-title":"To battle the opioid overdose epidemic, deploy the \u2018cascade of care\u2019 model"},{"issue":"1","key":"pone.0345769.ref057","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1080\/08897077.2022.2074604","article-title":"Opioid use disorder Cascade of care framework design: A roadmap","volume":"43","author":"AR Williams","year":"2022","journal-title":"Subst Abus"},{"key":"pone.0345769.ref058","article-title":"Making the opioid use disorder cascade of care a reality, despite data limitations","author":"K Johnson","journal-title":"Health Aff Forefr"},{"issue":"1","key":"pone.0345769.ref059","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/24734306.2020.1869899","article-title":"Care cascade for patients with opioid use disorder and serious injection related infections","volume":"5","author":"A Upadhyaya","year":"2021","journal-title":"Toxicol Commun"},{"issue":"9","key":"pone.0345769.ref060","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jamapsychiatry.2021.0976","article-title":"Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence: A Systematic Review and Meta-analysis","volume":"78","author":"T Santo","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"pone.0345769.ref061","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.eclinm.2019.07.013","article-title":"Modelling Long-Term Joint Trajectories of Heroin Use and Treatment Utilisation: Findings from the Australian Treatment Outcome Study","volume":"14","author":"C Marel","year":"2019","journal-title":"EClinicalMedicine"},{"issue":"1","key":"pone.0345769.ref062","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/ADM.0000000000000274","article-title":"Distinctive Trajectories of Opioid Use Over an Extended Follow-up of Patients in a Multisite Trial on Buprenorphine\u200a+\u200aNaloxone and Methadone","volume":"11","author":"Y-I Hser","year":"2017","journal-title":"J Addict Med"},{"key":"pone.0345769.ref063","first-page":"483","article-title":"Estimating State Transitions for Opioid Use Disorders. Med Decis Making","volume":"37","author":"E Krebs","year":"2017","journal-title":"SAGE Publications Inc STM"},{"issue":"9","key":"pone.0345769.ref064","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/add.14991","article-title":"Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services","volume":"115","author":"N Krawczyk","year":"2020","journal-title":"Addiction"},{"issue":"5","key":"pone.0345769.ref065","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1080\/10826084.2025.2586255","article-title":"People Who Use Illegal Opioids Use of Methadone over Time, and What Characteristics Are Correlated with Staying in Methadone Maintenance Treatment","volume":"61","author":"D Frank","year":"2026","journal-title":"Subst Use Misuse"},{"issue":"6","key":"pone.0345769.ref066","first-page":"1809","article-title":"Do Different Methods for Modeling Age-Graded Trajectories Yield Consistent and Valid Results?","volume":"120","author":"JR Warren","year":"2015","journal-title":"AJS"},{"key":"pone.0345769.ref067","author":"M Raab","year":"2023"},{"issue":"1","key":"pone.0345769.ref068","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.so.21.080195.000521","article-title":"Sequence Analysis: New Methods for Old Ideas","volume":"21","author":"A Abbott","year":"1995","journal-title":"Annu Rev Sociol"},{"issue":"3","key":"pone.0345769.ref069","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1177\/0049124109357532","article-title":"New Life for Old Ideas: The \u201cSecond Wave\u201d of Sequence Analysis Bringing the \u201cCourse\u201d Back Into the Life Course","volume":"38","author":"S Aisenbrey","year":"2010","journal-title":"Sociological Methods & Research"},{"issue":"24","key":"pone.0345769.ref070","doi-asserted-by":"crossref","first-page":"13398","DOI":"10.3390\/ijerph182413398","article-title":"Use of State Sequence Analysis in Pharmacoepidemiology: A Tutorial","volume":"18","author":"J Vanoli","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"6","key":"pone.0345769.ref071","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1080\/14740338.2017.1325463","article-title":"Methods for safety signal detection in healthcare databases: a literature review","volume":"16","author":"M Arnaud","year":"2017","journal-title":"Expert Opin Drug Saf"},{"issue":"5","key":"pone.0345769.ref072","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/acps.13411","article-title":"Antipsychotic utilization trajectories three years after initiating or reinitiating treatment of schizophrenia: A state sequence analysis approach","volume":"145","author":"S Brodeur","year":"2022","journal-title":"Acta Psychiatr Scand"},{"key":"pone.0345769.ref073","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12913-015-0857-5","article-title":"Mining care trajectories using health administrative information systems: the use of state sequence analysis to assess disparities in prenatal care consumption","volume":"15","author":"N Le Meur","year":"2015","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"pone.0345769.ref074","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12913-020-5030-0","article-title":"Healthcare utilization after a first hospitalization for COPD: a new approach of State Sequence Analysis based on the \u201c6W\u201d multidimensional model of care trajectories","volume":"20","author":"A Vanasse","year":"2020","journal-title":"BMC Health Serv Res"},{"key":"pone.0345769.ref075","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.puhe.2018.01.007","article-title":"The \u201c6W\u201d multidimensional model of care trajectories for patients with chronic ambulatory care sensitive conditions and hospital readmissions","volume":"157","author":"A Vanasse","year":"2018","journal-title":"Public Health"},{"key":"pone.0345769.ref076","doi-asserted-by":"crossref","first-page":"1014793","DOI":"10.3389\/fpain.2022.1014793","article-title":"Distinct care trajectories among persons living with arthritic conditions: A two-year state sequence analysis","volume":"3","author":"HL Nguena Nguefack","year":"2022","journal-title":"Front Pain Res (Lausanne)"},{"issue":"1","key":"pone.0345769.ref077","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41537-022-00256-6","article-title":"Multidimensional analysis of adult patients\u2019 care trajectories before a first diagnosis of schizophrenia","volume":"8","author":"A Vanasse","year":"2022","journal-title":"Schizophrenia (Heidelb)"},{"issue":"1","key":"pone.0345769.ref078","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s12877-023-03926-x","article-title":"Trajectories of care of community-dwelling people living with dementia: a multidimensional state sequence analysis","volume":"23","author":"I Dufour","year":"2023","journal-title":"BMC Geriatr"},{"issue":"1","key":"pone.0345769.ref079","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12913-021-07450-9","article-title":"Exploring social inequalities in healthcare trajectories following diagnosis of diabetes: a state sequence analysis of linked survey and administrative data","volume":"22","author":"TORSADE Cohort Working Group","year":"2022","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"pone.0345769.ref080","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12871-021-01434-2","article-title":"Circulatory trajectories after out-of-hospital cardiac arrest: a prospective cohort study","volume":"21","author":"H Langeland","year":"2021","journal-title":"BMC Anesthesiol"},{"issue":"6","key":"pone.0345769.ref081","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/add.70008","article-title":"State sequence analysis of daily methadone dispensing trajectories among individuals at United States opioid treatment programs before and following COVID-19 onset","volume":"120","author":"I B\u00f3rquez","year":"2025","journal-title":"Addiction"},{"key":"pone.0345769.ref082","article-title":"Trajectory modelling techniques useful to epidemiological research: a comparative narrative review of approaches","volume":"12","author":"HLN Nguefack","year":"2020","journal-title":"Clin Epidemiol"},{"issue":"1","key":"pone.0345769.ref083","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12874-023-01993-7","article-title":"Capturing the variety of clinical pathways in patients with schizophrenic disorders through state sequences analysis","volume":"23","author":"L Savar\u00e9","year":"2023","journal-title":"BMC Med Res Methodol"},{"issue":"6","key":"pone.0345769.ref084","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1177\/0962280218772068","article-title":"Use of state sequence analysis for care pathway analysis: The example of multiple sclerosis","volume":"28","author":"J Roux","year":"2019","journal-title":"Stat Methods Med Res"},{"issue":"2","key":"pone.0345769.ref085","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/eurpub\/ckx169","article-title":"Applying sequence clustering techniques to explore practice-based ambulatory care pathways in insurance claims data","volume":"28","author":"V Vogt","year":"2018","journal-title":"Eur J Public Health"},{"key":"pone.0345769.ref086","author":"New York State Department of Health","year":"2025"},{"key":"pone.0345769.ref087","volume-title":"Unintentional Drug Poisoning (Overdose) Deaths in New York City in 2024","author":"E Tuazon","year":"2025"},{"key":"pone.0345769.ref088","author":"D McCarthy","year":"2008"},{"key":"pone.0345769.ref089","volume-title":"Community Health Needs Assessment 2022","author":"NYC Health Hospitals","year":"2022"},{"key":"pone.0345769.ref090","article-title":"Application of an Opioid Use Disorder Cascade of Care in a Large Public Health System","author":"E Carter","year":"2023","journal-title":"medRxiv"},{"issue":"3","key":"pone.0345769.ref091","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/add.16071","article-title":"Association between jail-based methadone or buprenorphine treatment for opioid use disorder and overdose mortality after release from New York City jails 2011-17","volume":"118","author":"S Lim","year":"2023","journal-title":"Addiction"},{"issue":"4","key":"pone.0345769.ref092","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/aje\/kwu313","article-title":"All-cause, drug-related, and HIV-related mortality risk by trajectories of jail incarceration and homelessness among adults in New York City","volume":"181","author":"S Lim","year":"2015","journal-title":"Am J Epidemiol"},{"issue":"11","key":"pone.0345769.ref093","article-title":"Influence of Jail Incarceration and Homelessness Patterns on Engagement in HIV Care and HIV Viral Suppression among New York City Adults Living with HIV\/AIDS","volume":"10","author":"S Lim","year":"2015","journal-title":"PLoS One"},{"key":"pone.0345769.ref094","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/aje\/kwr327","article-title":"Risks of drug-related death, suicide, and homicide during the immediate post-release period among people released from New York City jails, 2001-2005","volume":"175","author":"S Lim","year":"2012","journal-title":"Am J Epidemiol"},{"issue":"3","key":"pone.0345769.ref095","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/ADM.0000000000001097","article-title":"Sensitivity of Medicaid Claims Data for Identifying Opioid Use Disorder in Patients Admitted to 6 New York City Public Hospitals","volume":"17","author":"J McNeely","year":"2023","journal-title":"J Addict Med"},{"key":"pone.0345769.ref096","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v040.i04","article-title":"Analyzing and Visualizing State Sequences in R with TraMineR","volume":"40","author":"A Gabadinho","year":"2011","journal-title":"J Stat Softw"},{"issue":"2","key":"pone.0345769.ref097","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/08897077.2019.1573776","article-title":"Rapid transition from methadone to buprenorphine using naltrexone-induced withdrawal: A case report","volume":"40","author":"HB Ward","year":"2019","journal-title":"Subst Abus"},{"key":"pone.0345769.ref098","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/EDE.0000000000001609","article-title":"Changes in opioid and benzodiazepine poisoning deaths after cannabis legalization in the US: a county-level analysis, 2002-2020","volume":"34","author":"A Castillo-Carniglia","year":"2023","journal-title":"Epidemiol Camb Mass"},{"issue":"5","key":"pone.0345769.ref099","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/add.16105","article-title":"COVID-19 complications among patients with opioid use disorder: a retrospective cohort study across five major NYC hospital systems","volume":"118","author":"N Krawczyk","year":"2023","journal-title":"Addiction"},{"issue":"5","key":"pone.0345769.ref100","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/EDE.0000000000001502","article-title":"When Effects Cannot be Estimated: Redefining Estimands to Understand the Effects of Naloxone Access Laws","volume":"33","author":"KE Rudolph","year":"2022","journal-title":"Epidemiology"},{"key":"pone.0345769.ref101","doi-asserted-by":"crossref","first-page":"103980","DOI":"10.1016\/j.drugpo.2023.103980","article-title":"Naloxone expansion is not associated with increases in adolescent heroin use and injection drug use: Evidence from 44 US states","volume":"114","author":"E Bruzelius","year":"2023","journal-title":"Int J Drug Policy"},{"key":"pone.0345769.ref102","first-page":"39","author":"L Bergroth","year":"2000"},{"key":"pone.0345769.ref103","doi-asserted-by":"crossref","first-page":"102772","DOI":"10.1016\/j.ssresearch.2022.102772","article-title":"Sequence analysis: Its past, present, and future","volume":"107","author":"TF Liao","year":"2022","journal-title":"Soc Sci Res"},{"key":"pone.0345769.ref104","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1080\/01621459.1963.10500845","article-title":"Hierarchical Grouping to Optimize an Objective Function","volume":"58","author":"JH Ward","year":"1963","journal-title":"J Am Stat Assoc"},{"key":"pone.0345769.ref105","volume-title":"Weightedcluster library manual: A practical guide to creating typologies of trajectories in the social sciences with R","author":"M Studer"},{"issue":"3","key":"pone.0345769.ref106","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1467-9876.2012.01066.x","article-title":"How to Find an Appropriate Clustering for Mixed-Type Variables with Application to Socio-Economic Stratification","volume":"62","author":"C Hennig","year":"2013","journal-title":"Journal of the Royal Statistical Society Series C: Applied Statistics"},{"key":"pone.0345769.ref107","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/00811750211014232","article-title":"Validating sequence analysis typologies using parametric bootstrap","volume":"51","author":"M Studer","year":"2021","journal-title":"Sociol Methodol"},{"issue":"5","key":"pone.0345769.ref108","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1111\/1475-6773.12849","article-title":"Impact of a New York City Supportive Housing Program on Housing Stability and Preventable Health Care among Homeless Families","volume":"53","author":"S Lim","year":"2018","journal-title":"Health Serv Res"},{"issue":"6","key":"pone.0345769.ref109","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1080\/10511482.2017.1316757","article-title":"Subsidized Housing and Residential Trajectories: An Application of Matched Sequence Analysis","volume":"27","author":"KO Lee","year":"2017","journal-title":"Housing Policy Debate"},{"issue":"1","key":"pone.0345769.ref110","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1177\/0049124117729697","article-title":"Causal Effects of the Timing of Life-course Events: Age at Retirement and Subsequent Health","volume":"49","author":"N Barban","year":"2017","journal-title":"Sociological Methods & Research"},{"key":"pone.0345769.ref111","author":"M Bulus","year":"2022"},{"key":"pone.0345769.ref112","unstructured":"Nguyen T. Racial and ethnic disparities in receipt of medications for opioid use disorder following emergency department visits in the Medicaid population. 2023."},{"key":"pone.0345769.ref113","doi-asserted-by":"crossref","first-page":"109763","DOI":"10.1016\/j.drugalcdep.2023.109763","article-title":"Transitions in care between hospital and community settings for individuals with a substance use disorder: A systematic review","volume":"243","author":"H James","year":"2023","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"pone.0345769.ref114","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1017\/cem.2020.438","article-title":"Multi-site intervention to improve emergency department care for patients who live with opioid use disorder: A quantitative evaluation","volume":"22","author":"P McLane","year":"2020","journal-title":"CJEM"},{"issue":"8","key":"pone.0345769.ref115","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s11606-017-4077-z","article-title":"Inpatient Addiction Consultation for Hospitalized Patients Increases Post-Discharge Abstinence and Reduces Addiction Severity","volume":"32","author":"SE Wakeman","year":"2017","journal-title":"J Gen Intern Med"},{"key":"pone.0345769.ref116","article-title":"Unequal burdens: assessing the determinants of elevated COVID-19 case and death rates in New York City\u2019s racial\/ethnic minority neighbourhoods","author":"DP Do","year":"2020","journal-title":"J Epidemiol Community Health"},{"issue":"4","key":"pone.0345769.ref117","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.3711","article-title":"Association of Racial\/Ethnic Segregation With Treatment Capacity for Opioid Use Disorder in Counties in the United States","volume":"3","author":"WC Goedel","year":"2020","journal-title":"JAMA Netw Open"},{"key":"pone.0345769.ref118","volume-title":"Racial and ethnic residential segregation in the United States 1980-2000","year":"2003"},{"key":"pone.0345769.ref119","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/0049124111415372","article-title":"Discrepancy Analysis of State Sequences","volume":"40","author":"M Studer","year":"2011","journal-title":"Sociol Methods Res"},{"issue":"6","key":"pone.0345769.ref120","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1177\/0962280218774811","article-title":"Categorical state sequence analysis and regression tree to identify determinants of care trajectory in chronic disease: Example of end-stage renal disease","volume":"28","author":"N Le Meur","year":"2019","journal-title":"Stat Methods Med Res"},{"key":"pone.0345769.ref121","article-title":"Who is least likely to access evidence-based treatment for OUD in NY State?","author":"J Santaella-Tenorio","journal-title":"Rev J Subst Use Addict Treat"},{"key":"pone.0345769.ref122","article-title":"Utilization and disparities in medication treatment for opioid use disorder among patients with comorbid opioid use disorder and chronic pain during the COVID-19 pandemic","author":"A Perry","year":"2023","journal-title":"Drug Alcohol Depend"},{"key":"pone.0345769.ref123","first-page":"375","article-title":"Combining Event History and Sequence Analysis to Study Vulnerability over the Life Course.","volume-title":"Withstanding Vulnerability: Adult Life Dynamics, Stress, Resources, and Reserves","author":"M Studer","year":"2023"},{"key":"pone.0345769.ref124","doi-asserted-by":"crossref","unstructured":"Rossignon F, Studer M, Jacques-Antoine G, Le Goff J-M. Sequence history analysis (SHA): Estimating the effect of past trajectories on an upcoming event. 2018. 83\u2013100.","DOI":"10.1007\/978-3-319-95420-2_6"},{"key":"pone.0345769.ref125","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1040-2608(05)10010-0","article-title":"Life course analysis: two (complementary) cultures? Some reflections with examples from the analysis of the transition to adulthood","volume":"10","author":"FC Billari","year":"2005","journal-title":"Advances in Life Course Research"},{"key":"pone.0345769.ref126","doi-asserted-by":"crossref","first-page":"100251","DOI":"10.1016\/j.alcr.2018.10.004","article-title":"Holistic analysis of the life course: Methodological challenges and new perspectives","volume":"41","author":"R Piccarreta","year":"2019","journal-title":"Adv Life Course Res"},{"issue":"4","key":"pone.0345769.ref127","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1080\/08897077.2020.1823548","article-title":"Characteristics and outcomes of hospitalizations and readmissions for opioid dependence and overdose: nationally representative data","volume":"42","author":"S Grzebinski","year":"2021","journal-title":"Subst Abus"},{"key":"pone.0345769.ref128","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.annemergmed.2019.04.020","article-title":"One-Year Mortality of Patients After Emergency Department Treatment for Nonfatal Opioid Overdose","volume":"75","author":"SG Weiner","year":"2020","journal-title":"Ann Emerg Med"},{"issue":"4","key":"pone.0345769.ref129","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1370\/afm.2098","article-title":"Mortality Associated With Time in and Out of Buprenorphine Treatment in French Office-Based General Practice: A 7-Year Cohort Study","volume":"15","author":"J Dupouy","year":"2017","journal-title":"Ann Fam Med"},{"issue":"1","key":"pone.0345769.ref130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/add.13087","article-title":"Risk of mortality on and off methadone substitution treatment in primary care: a national cohort study","volume":"111","author":"G Cousins","year":"2016","journal-title":"Addiction"},{"key":"pone.0345769.ref131","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/add.12863","article-title":"Mortality among individuals accessing pharmacological treatment for opioid dependence in California, 2006-10","volume":"110","author":"E Evans","year":"2015","journal-title":"Addict Abingdon Engl"},{"issue":"3","key":"pone.0345769.ref132","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality: A Cohort Study","volume":"169","author":"MR Larochelle","year":"2018","journal-title":"Ann Intern Med"},{"key":"pone.0345769.ref133","article-title":"Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study","volume":"368","author":"LA Pearce","year":"2020","journal-title":"BMJ"},{"key":"pone.0345769.ref134","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jsat.2016.12.005","article-title":"Mortality related to methadone maintenance treatment in Stockholm, Sweden, during 2006-2013","volume":"74","author":"A Ledberg","year":"2017","journal-title":"J Subst Abuse Treat"},{"issue":"3","key":"pone.0345769.ref135","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.0595","article-title":"Association of Methadone Treatment With Substance-Related Hospital Admissions Among a Population in Canada With a History of Criminal Convictions","volume":"2","author":"A Russolillo","year":"2019","journal-title":"JAMA Netw Open"},{"key":"pone.0345769.ref136","doi-asserted-by":"crossref","first-page":"109269","DOI":"10.1016\/j.drugalcdep.2022.109269","article-title":"Opioid overdose survivors: Medications for opioid use disorder and risk of repeat overdose in Medicaid patients","volume":"232","author":"S Crystal","year":"2022","journal-title":"Drug Alcohol Depend"},{"key":"pone.0345769.ref137","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/ADM.0000000000000499","article-title":"Predictors for 30-Day and 90-Day Hospital Readmission Among Patients With Opioid Use Disorder","volume":"13","author":"JL Moreno","year":"2019","journal-title":"J Addict Med"},{"key":"pone.0345769.ref138","author":"W Qiu","year":"2009"},{"key":"pone.0345769.ref139","author":"Q Yang","year":"2017","journal-title":"powerCompRisk: Power Analysis Tool for Joint Testing Hazards with Competing Risks Data"},{"key":"pone.0345769.ref140","year":"2023"},{"issue":"9","key":"pone.0345769.ref141","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1001\/jamainternmed.2024.3422","article-title":"Addiction Consultation Services for Opioid Use Disorder Treatment Initiation and Engagement: A Randomized Clinical Trial","volume":"184","author":"J McNeely","year":"2024","journal-title":"JAMA Intern Med"},{"key":"pone.0345769.ref142","author":"Massachusetts Department of Public Health"},{"key":"pone.0345769.ref143","doi-asserted-by":"crossref","first-page":"108837","DOI":"10.1016\/j.jsat.2022.108837","article-title":"Emergency department interventions for opioid use disorder: A synthesis of emerging models","volume":"141","author":"CP Thomas","year":"2022","journal-title":"J Subst Abuse Treat"},{"issue":"9","key":"pone.0345769.ref144","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/jhm.12908","article-title":"Management of opioid use disorder, opioid withdrawal, and opioid overdose prevention in hospitalized adults: A systematic review of existing guidelines","volume":"17","author":"SL Calcaterra","year":"2022","journal-title":"J Hosp Med"},{"key":"pone.0345769.ref145","doi-asserted-by":"crossref","first-page":"110950","DOI":"10.1016\/j.drugalcdep.2023.110950","article-title":"Identification of opioid use disorder using electronic health records: Beyond diagnostic codes","volume":"251","author":"MN Poulsen","year":"2023","journal-title":"Drug Alcohol Depend"},{"key":"pone.0345769.ref146","author":"Bureau UC"},{"issue":"2","key":"pone.0345769.ref147","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10742-009-0047-1","article-title":"Using the Census Bureau\u2019s surname list to improve estimates of race\/ethnicity and associated disparities","volume":"9","author":"MN Elliott","year":"2009","journal-title":"Health Serv Outcomes Res Method"},{"key":"pone.0345769.ref148","author":"Bureau UC","year":"2020"},{"key":"pone.0345769.ref149","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/infdis\/jiac448","article-title":"Pfizer-BioNTech Coronavirus Disease 2019 Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Long-Term Care Facility Staff With and Without Prior Infection in New York City, January\u2013June 2021","volume":"227","author":"K Peebles","year":"2023","journal-title":"J Infect Dis"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0345769","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T17:32:59Z","timestamp":1777570379000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0345769"}},"subtitle":[],"editor":[{"given":"Katherine Demi","family":"Kokkinias","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":149,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0345769","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]}}}